Skip to main content
Erschienen in: Journal of Diabetes & Metabolic Disorders 1/2021

07.01.2021 | COVID-19 | Research article Zur Zeit gratis

Risk indicators associated with in-hospital mortality and severity in patients with diabetes mellitus and confirmed or clinically suspected COVID-19

verfasst von: Marzieh Pazoki, Mohammad Keykhaei, Samira Kafan, Mahnaz Montazeri, Mojgan Mirabdolhagh Hazaveh, Mehran Sotoodehnia, Sina Kazemian, Mohammad Talebpour, Haleh Ashraf, Reza Shariat Moharari, Fazeleh Majidi, Nazanin Hedayati Amlashi, Sara Zare, Maryam Fathi, Zohre Azimbeik, Mehdi Ebrahimi

Erschienen in: Journal of Diabetes & Metabolic Disorders | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This study aims to investigate risk indicators of in-hospital mortality and severity of coronavirus disease-2019 (COVID-19) in patients with diabetes mellitus (DM).

Methods

In this retrospective study, we studied patients with COVID-19 referred to Sina Hospital, Tehran, Iran, from February 20 to May 14, 2020. Patients with either a positive real-time reverse-transcriptase polymerase-chain-reaction test of swab specimens or high clinical suspicion according to the World Health Organization interim guidance were included. We accurately divided all patients into two groups based on diabetes affection and followed-up patients with DM based on incurring death, severe COVID-19, and in-hospital complications.

Results

We enrolled 574 patients with COVID-19 in the final analysis, of whom 176 (30.7%) patients had DM. In this study, 104 (18.1%) patients deceased, and 380 (66.2%) patients incurred severe COVID-19. We found that COVID-19 patients with DM had a significantly higher mortality rate (P value<0.001), severe disease (P value<0.001), and in-hospital complications (all P values<0.05). Besides that, in patients with DM, admission temperature (odds ratio (OR): 1.69, P value: 0.024), oxygen saturation (OR: 0.92, P value: 0.004), and urea (OR: 1.01, P value: 0.048) were independent risk indicators of in-hospital mortality. In addition, subgroup analysis of diabetic patients based on admission glucose level showed significant differences between these groups regarding acute cardiac injury (P value: 0.044) and acute liver injury (P value: 0.002).

Conclusions

Patients with DM admitted with lower oxygen saturation, elevated temperature, and higher urea are more susceptible to progress to more severe COVID-19 and poor prognosis. This indicates a necessity for more precise care during hospitalization for these patients.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
3.
Zurück zum Zitat Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–13.CrossRef Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–13.CrossRef
4.
Zurück zum Zitat Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2020;94:91–5. https://doi.org/10.1016/j.ijid.2020.03.017.CrossRef Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2020;94:91–5. https://​doi.​org/​10.​1016/​j.​ijid.​2020.​03.​017.CrossRef
5.
Zurück zum Zitat Badawi A, Ryoo SG. Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2016;49:129–33. https://doi.org/10.1016/j.ijid.2016.06.015.CrossRef Badawi A, Ryoo SG. Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2016;49:129–33. https://​doi.​org/​10.​1016/​j.​ijid.​2016.​06.​015.CrossRef
9.
Zurück zum Zitat Rossi G, Association AD. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2018;33(Suppl 1):S62–S9. Rossi G, Association AD. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2018;33(Suppl 1):S62–S9.
10.
Zurück zum Zitat Allard R, Leclerc P, Tremblay C, Tannenbaum T-N. Diabetes and the severity of pandemic influenza a (H1N1) infection. Diabetes Care. 2010;33(7):1491–3.CrossRef Allard R, Leclerc P, Tremblay C, Tannenbaum T-N. Diabetes and the severity of pandemic influenza a (H1N1) infection. Diabetes Care. 2010;33(7):1491–3.CrossRef
16.
Zurück zum Zitat Talebpour M, Hadadi A, Oraii A, Ashraf H. Rationale and Design of a Registry in a Referral and Educational Medical Center in Tehran, Iran: Sina Hospital Covid-19 Registry (SHCo-19R). Advanced Journal of Emergency Medicine. 2020;4(2s):e53–e. Talebpour M, Hadadi A, Oraii A, Ashraf H. Rationale and Design of a Registry in a Referral and Educational Medical Center in Tehran, Iran: Sina Hospital Covid-19 Registry (SHCo-19R). Advanced Journal of Emergency Medicine. 2020;4(2s):e53–e.
20.
Zurück zum Zitat Adams J 3rd, Bodor GS, Davila-Roman VG, Delmez JA, Apple FS, Ladenson J, et al. Cardiac troponin I. A marker with high specificity for cardiac injury circulation. 1993;88(1):101–6.PubMed Adams J 3rd, Bodor GS, Davila-Roman VG, Delmez JA, Apple FS, Ladenson J, et al. Cardiac troponin I. A marker with high specificity for cardiac injury circulation. 1993;88(1):101–6.PubMed
21.
Zurück zum Zitat Makris K, Spanou L. Acute kidney injury: definition, pathophysiology and clinical phenotypes. The Clinical biochemist Reviews. 2016;37(2):85–98.PubMedPubMedCentral Makris K, Spanou L. Acute kidney injury: definition, pathophysiology and clinical phenotypes. The Clinical biochemist Reviews. 2016;37(2):85–98.PubMedPubMedCentral
22.
Zurück zum Zitat Dufour DR, Lott JA, Nolte FS, Gretch DR, Koff RS, Seeff LB. Diagnosis and monitoring of hepatic injury. I. Performance characteristics of laboratory tests. Clin Chem. 2000;46(12):2027–49.CrossRef Dufour DR, Lott JA, Nolte FS, Gretch DR, Koff RS, Seeff LB. Diagnosis and monitoring of hepatic injury. I. Performance characteristics of laboratory tests. Clin Chem. 2000;46(12):2027–49.CrossRef
26.
Zurück zum Zitat Soleimani A, Kazemian S, Karbalai Saleh S, Aminorroaya A, Shajari Z, Hadadi A, et al. Effects of angiotensin receptor blockers (ARBs) on in-hospital outcomes of patients with hypertension and confirmed or clinically suspected COVID-19. Am J Hypertens. 2020. https://doi.org/10.1093/ajh/hpaa149. Soleimani A, Kazemian S, Karbalai Saleh S, Aminorroaya A, Shajari Z, Hadadi A, et al. Effects of angiotensin receptor blockers (ARBs) on in-hospital outcomes of patients with hypertension and confirmed or clinically suspected COVID-19. Am J Hypertens. 2020. https://​doi.​org/​10.​1093/​ajh/​hpaa149.
42.
Zurück zum Zitat Zhang Y, Li H, Zhang J, Cao Y, Zhao X, Yu N, et al. The clinical characteristics and outcomes of patients with diabetes and secondary hyperglycaemia with coronavirus disease 2019: a single-Centre, retrospective, observational study in Wuhan. Diabetes Obes Metab. 2020;22(8):1443–54. https://doi.org/10.1111/dom.14086.CrossRefPubMed Zhang Y, Li H, Zhang J, Cao Y, Zhao X, Yu N, et al. The clinical characteristics and outcomes of patients with diabetes and secondary hyperglycaemia with coronavirus disease 2019: a single-Centre, retrospective, observational study in Wuhan. Diabetes Obes Metab. 2020;22(8):1443–54. https://​doi.​org/​10.​1111/​dom.​14086.CrossRefPubMed
Metadaten
Titel
Risk indicators associated with in-hospital mortality and severity in patients with diabetes mellitus and confirmed or clinically suspected COVID-19
verfasst von
Marzieh Pazoki
Mohammad Keykhaei
Samira Kafan
Mahnaz Montazeri
Mojgan Mirabdolhagh Hazaveh
Mehran Sotoodehnia
Sina Kazemian
Mohammad Talebpour
Haleh Ashraf
Reza Shariat Moharari
Fazeleh Majidi
Nazanin Hedayati Amlashi
Sara Zare
Maryam Fathi
Zohre Azimbeik
Mehdi Ebrahimi
Publikationsdatum
07.01.2021
Verlag
Springer International Publishing
Schlagwort
COVID-19
Erschienen in
Journal of Diabetes & Metabolic Disorders / Ausgabe 1/2021
Elektronische ISSN: 2251-6581
DOI
https://doi.org/10.1007/s40200-020-00701-2

Weitere Artikel der Ausgabe 1/2021

Journal of Diabetes & Metabolic Disorders 1/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.